NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission, PerkinElmer reported it has entered into a new credit agreement with the ability to borrow up to $1 billion through Aug. 11, 2021.

The company said it will use the proceeds from the unsecured revolving credit facility for working capital, capital expenditures, repurchases of equity, dividends, permitted acquisitions, and to pay fees and expenses for the new credit agreement and to terminate its prior credit agreement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.